Abstract:
본명세서는비대칭탄소원자에아민기가결합된화합물의입체이성질체혼합물을카이랄보조체및 염-형성보조화합물과혼합시키는단계를포함하는입체이성질체혼합물의카이랄분할방법에관한것이다. 이때, 카이랄보조체는 2,3-디벤조일-타르타르산또는-디--톨루오일타르타르산이고, 염-형성보조화합물은만델산또는캄포르술폰산이며, 이러한방법에의하면높은수준의광학순도를가지는광학이성질체를얻는것이가능하다. 따라서, 본발명의일 측면에따른방법은약학또는제약분야에서단일한형태의광학이성질체를가지는화합물을높은순도로수득하고자하는경우에유용하게사용될수 있다.
Abstract:
일측면에서 본 발명은 21-O-안젤로일티아사포제놀 E3을 유효성분으로 함유하는 발모 또는 육모 촉진용 조성물에 관한 것이다. 다른 일측면에서 본 발명은 모유두 세포증식 및 인체 모낭기관에서의 모발 성장을 촉진시켜 성장주기 중 휴지기에서 성장기로 이행되는 주기를 단축시켜주는 것을 특징으로 하는 21-O-안젤로일티아사포제놀 E3을 포함하는 조성물에 관한 것이다.
Abstract:
The present invention relates to a novel phenylacetic acid amide derivative compound, isomers thereof, pharmaceutically acceptable salt thereof, prodrug thereof, a hydrate or a solvate thereof, and a composition for skin whitening comprising the same. The novel compound or the like has excellent skin whitening effect.
Abstract:
본 발명은 바닐로이드 수용체(바닐로이드 수용체 1; VR1; TRPV1) 길항제로서의 신규 화합물, 그의 이성질체 또는 약제학적으로 허용가능한 그의 염; 및 이를 함유하는 약제학적 조성물에 관한 것이다. 본 발명은 통증, 편두통, 관절통, 신경통, 신경 장해, 신경 손상, 피부 질환, 방광 과민증, 과민성 대장 증후군, 대변절박증, 호흡 질환, 피부자극, 눈 또는 점막의 염증, 위-십이지장 궤양, 염증성 질환, 귀 질환, 심장 질환 등과 같은 질병의 예방 또는 치료를 위한 약제학적 조성물을 제공한다.
Abstract:
The present invention provides a novel pseudo-ceramide compound represented by Chemical Formula 1, an isomer thereof, a pharmaceutically acceptable salt thereof, a pro-drug thereof, a hydrate thereof, and a solvate thereof. [Chemical Formula 1] (In Chemical Formula 1, R is a C9 to 17 saturated or unsaturated aliphatic chain, and R′ is an amino group or an alkoxy group having a C10 to 18 saturated aliphatic chain.) According to the present invention, the novel pseudo-ceramide compound has a skin protecting effect by having excellent stability, dissolubility, and skin moisturization, so that the novel pseudo-ceramide compound can be used as an active ingredient for protecting the skin from external stimuli without side effects, preventing the skin from damage, and recovering damaged skin. Accordingly, the novel pseudo-ceramide compound can be used as a skin-moisturizing composition for external application on skin, a cosmetic composition, or a pharmaceutical composition.
Abstract:
The present invention relates to a microcapsule comprising glycoprotein derived from plants. More specifically, the present invention provides a microcapsule comprising polysaccharides with a negative net charge, protein having 4-6 isoelectric point (PI), and glycoprotein derived from plants with a negative net charge; and a method for manufacturing the microcapsule. [Reference numerals] (AA) Example 1; (BB) Example 2; (CC) Example 3; (DD) Example 4; (EE) Example 5; (FF) Example 6; (GG) Example 7; (HH) Example 8; (II) Example 9; (JJ) Example 10; (KK) Example 11; (LL) Example 12; (MM) Example 13; (NN) Example 14; (OO) Example 15; (PP) Example 16; (QQ) Example 17; (RR) Example 18; (SS) Example 19; (TT) Example 20; (UU) Example 21; (VV) Example 22
Abstract:
PURPOSE: A skin irritation relieving agent containing carnosic acid or a derivative thereof is provided to suppress release of IL-8(interleukin-8), MCP-1(monocyte chemotactic protein-1), and IL-6(interleukin-6), and to relieves skin irritation due to retinoid or surfactant. CONSTITUTION: A skin irritation relieving agent contains carnosic acid denoted by chemical formula 1, a derivative thereof, or pharmaceutically acceptable salt thereof as an active ingredient. The skin irritation relieving agent relieves inflammation, skin dryness, erythema, horny substance, itching, or burning sensation. The skin irritation is caused by retinoid or surfactant of an external use skin formulation. The retinoid is selected from the group consisting of retinol, retinal, and retinoic acid.
Abstract:
PURPOSE: A method for preparing a kojic acid derivative is provided to obtain a high purity kojic acid derivative by reacting halogenated kojic acid, which is the product of substituting a halogen element for a hydroxyl group of a hydroxyl methyl group, with benzoate or cinnamate. CONSTITUTION: A method for preparing a kojic acid derivative of chemical formula 1 comprises a step of reacting halogenated kojic acid with benzoate or cinnamate under the presence of acid. In chemical formula 1, R_1 is -CH_2- or -CH_2CH_2-; and R_2 is -C(O)OCH_2- or -CH=CHC(O)OCH_2-.